Low systemic vitamin D as a potential risk factor in primary open-angle glaucoma: a review of current evidence.


Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
05 2021
Historique:
received: 16 03 2020
accepted: 12 06 2020
revised: 04 06 2020
pubmed: 2 7 2020
medline: 3 8 2021
entrez: 2 7 2020
Statut: ppublish

Résumé

Currently, intraocular pressure is the only modifiable risk factor for glaucoma; thus, identifying other modifiable determinants may have far-reaching outcomes. There has been increasing interest in vitamin D status and glaucoma pathogenesis as low vitamin D has been identified by some studies as an independent risk factor for glaucoma. Although the exact mechanism of vitamin D in glaucoma remains uncertain, there is sufficient evidence to continue research in this area. There is a potential physiological role for vitamin D as an anti-inflammatory agent in the oxidative stress-driven pathogenesis of primary open-angle glaucoma, and further studies are required to evaluate the temporal and causal relationship. Ocular vitamin D status in the tear, aqueous and vitreous fluid is a prospective gap in research.

Identifiants

pubmed: 32606080
pii: bjophthalmol-2020-316331
doi: 10.1136/bjophthalmol-2020-316331
doi:

Substances chimiques

Vitamins 0
Vitamin D 1406-16-2

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

595-601

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Brandon Huynh (B)

Westmead Hospital, Westmead, Australia b.huynh@live.com.

Peter Shah (P)

Department of Ophthalmology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Birmingham Institute for Glaucoma Research, Institute of Translational Medicine, Birmingham, UK.
University College London, London, UK.
Centre for Health and Social Care Improvement, University of Wolverhampton, Wolverhampton, UK.

Freda Sii (F)

Department of Ophthalmology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Birmingham Institute for Glaucoma Research, Institute of Translational Medicine, Birmingham, UK.

Damien Hunter (D)

Centre for Vision Research, Westmead Institute for Medical Research, Westmead, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, Australia.

Nicole Carnt (N)

Centre for Vision Research, Westmead Institute for Medical Research, Westmead, Australia.
School of Optometry and Vision Science, University of New South Wales, Sydney, Australia.

Andrew White (A)

School of Optometry and Vision Science, University of New South Wales, Sydney, Australia.
Cambridge NIHR Biomedical Research Centre, University of Cambridge, Cambridge, UK.
Department of Ophthalmology, Westmead Hospital, Westmead, Australia.
Community Eye Care Centre, Western Sydney, Australia.
Sydney Medical School, Westmead Institute, Sydney, Australia.
Sydney Medical School, Save Sight Institute, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH